Cargando…

Serum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes

It has been known for over 20 years that foetal calf serum can induce hypertrophy in cultured cardiomyocytes but this is rarely considered when examining cardiomyocytes derived from pluripotent stem cells (PSC). Here, we determined how serum affected cardiomyocytes from human embryonic- (hESC) and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dambrot, Cheryl, Braam, Stefan R, Tertoolen, Leon G J, Birket, Matthew, Atsma, Douwe E, Mummery, Christine L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190898/ https://www.ncbi.nlm.nih.gov/pubmed/24981391 http://dx.doi.org/10.1111/jcmm.12356

Ejemplares similares

Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function
por: Birket, Matthew J., et al.
Publicado: (2015)

Interpretation of field potentials measured on a multi electrode array in pharmacological toxicity screening on primary and human pluripotent stem cell-derived cardiomyocytes
por: Tertoolen, L.G.J., et al.
Publicado: (2018)

Concise Review: Measuring Physiological Responses of Human Pluripotent Stem Cell Derived Cardiomyocytes to Drugs and Disease
por: van Meer, Berend J., et al.
Publicado: (2016)

Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)
por: Sala, Luca, et al.
Publicado: (2017)

Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells
por: Giacomelli, Elisa, et al.
Publicado: (2017)

Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
por: Brandão, Karina O., et al.
Publicado: (2017)

Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
por: Mummery, Christine L.
Publicado: (2018)

Aberrant α-Adrenergic Hypertrophic Response in Cardiomyocytes from Human Induced Pluripotent Cells
por: Földes, Gabor, et al.
Publicado: (2014)

Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Enables Modeling of Human Hypertrophic Cardiomyopathy
por: Knight, Walter E., et al.
Publicado: (2021)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
por: Li, Jiangtao, et al.
Publicado: (2022)

Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes
por: van Meer, Berend J., et al.
Publicado: (2019)

Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
por: Giacomelli, E., et al.
Publicado: (2017)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?
por: Sala, Luca, et al.
Publicado: (2016)

Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes
por: Saleem, Umber, et al.
Publicado: (2020)

Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3′,5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lin, Bin, et al.
Publicado: (2017)

MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling
por: Li, Xiaowei, et al.
Publicado: (2019)

Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes
por: Chu, Axel J., et al.
Publicado: (2020)

Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
por: Le, Minh Nguyen Tuyet, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy masked by pericarditis
por: Nichols, Larry, et al.
Publicado: (2019)

Suppressive effects of induced pluripotent stem cell-conditioned medium on in vitro hypertrophic scarring fibroblast activation
por: REN, YE, et al.
Publicado: (2015)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
por: Prajapati, Chandra, et al.
Publicado: (2018)

RAD-Deficient Human Cardiomyocytes Develop Hypertrophic Cardiomyopathy Phenotypes Due to Calcium Dysregulation
por: Li, Ya’nan, et al.
Publicado: (2020)

SNTA1-deficient human cardiomyocytes demonstrate hypertrophic phenotype and calcium handling disorder
por: Dong, Tao, et al.
Publicado: (2022)

Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties
por: van den Brink, Lettine, et al.
Publicado: (2020)

Integrins Are the Necessary Links to Hypertrophic Growth in Cardiomyocytes
por: Harston, Rebecca K., et al.
Publicado: (2011)

Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture
por: Batalov, Ivan, et al.
Publicado: (2015)

A six-inhibitor culture medium for improving naïve-type pluripotency of porcine pluripotent stem cells
por: Yuan, Ye, et al.
Publicado: (2019)

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: Tanaka, Atsushi, et al.
Publicado: (2014)

Investigating the cardiac pathology of SCO2‐mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell–derived cardiomyocytes
por: Hallas, Tova, et al.
Publicado: (2017)

Apical Hypertrophic Cardiomyopathy Masked by Takotsubo Syndrome
por: Gherbesi, Elisa, et al.
Publicado: (2020)

Familial hypertrophic cardiomyopathy: functional variance among individual cardiomyocytes as a trigger of FHC-phenotype development
por: Brenner, Bernhard, et al.
Publicado: (2014)

Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation
por: Seok, Heeyoung, et al.
Publicado: (2021)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Suspension culture improves iPSC expansion and pluripotency phenotype
por: Cuesta-Gomez, Nerea, et al.
Publicado: (2023)

Effects of astaxanthin supplementation in fertilization medium and/or culture medium on the fertilization and development of mouse oocytes
por: Tana, Chonthicha, et al.
Publicado: (2022)

Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome
por: Bellin, Milena, et al.
Publicado: (2013)

PGC-1α and Reactive Oxygen Species Regulate Human Embryonic Stem Cell-Derived Cardiomyocyte Function
por: Birket, Matthew J., et al.
Publicado: (2013)

A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
por: Sala, Luca, et al.
Publicado: (2016)

Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes
por: Horikoshi, Yuichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8mf86kotst2g4mmj8j94efgbbo